Last reviewed · How we verify
NCT04231799: TEWL
Delaying First Bathing and Skin Barrier Function on Infant
NA trial testing Bathing in Premature in 80 participants. Completed in 1 September 2022.
1 September 2021
Quick facts
| Lead sponsor | Akdeniz University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 20 February 2020 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Bathing
Conditions studied
- Premature — all drugs for Premature →
- Thermoregulation — all drugs for Thermoregulation →
Sponsor
Akdeniz University
Who can join
Adults 24 Hours to 72 Hours, any sex, with Premature or Thermoregulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is still unknown when the first bath should be done in premature newborns. Investigators think that delaying the time of the first bath compared to the time in the clinic will show some positive changes in preterm newborns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04231799
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bathing
Trials testing the same drug.
- NCT05135429 — Effect of Bathing on Pain, Sleep and Vital Signs of Premature Babies · NA · completed
Other recruiting trials for Premature
Currently open trials in the same condition.
- NCT07371845 — Effect of Teach-Back Education on Breastfeeding and Bonding in Mothers of Preterm Infants · NA · recruiting
- NCT07049900 — Baby ABS (Abdominal Binder Study) · NA · recruiting
- NCT07154186 — Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients · recruiting
- NCT07088302 — Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates · NA · recruiting
- NCT06812507 — Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their He · NA · recruiting
Other Akdeniz University trials
Trials by the same sponsor.
- NCT07581132 — Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients · NA · not yet recruiting
- NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
- NCT07507279 — Technology-based Hand Rehabilitation in Older People · NA · not yet recruiting
- NCT07437924 — Bruxism and Pelvic Floor Dysfunction in Young Women · enrolling by invitation
- NCT07497308 — GDF-15 and Early Outcomes After LVAD Implantation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04231799 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Akdeniz University
- Last refreshed: 3 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04231799.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing